학술논문
Frequency and prognostic significance of access site and non-access site bleeding and impact of choice of antithrombin therapy in patients undergoing primary percutaneous coronary intervention. The EUROMAX trial
Document Type
Article
Author
Source
In International Journal of Cardiology 15 May 2016 211:119-123
Subject
Language
ISSN
0167-5273